Home Polyglandular autoimmune syndrome type I – a novel AIRE mutation in a North American patient
Article
Licensed
Unlicensed Requires Authentication

Polyglandular autoimmune syndrome type I – a novel AIRE mutation in a North American patient

  • Kelly Egan Huibregtse EMAIL logo , Peter Wolfgram , Karen K. Winer and Ellen L. Connor
Published/Copyright: June 19, 2014

Abstract

Autoimmune polyglandular syndrome type 1 (APS-1), also referred to as autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), is a rare autoimmune disease that results from autosomal recessive mutations of the human autoimmune regulatory (AIRE) gene. We present the case of a 17-year-old North American girl of primarily Norwegian descent with a novel AIRE gene mutation causing APS-1. In addition to the classic triad of chronic candidiasis, hypoparathyoidism and autoimmune adrenocortical insufficiency, she also has vitiligo, intestinal malabsorption, autoimmune hepatitis, autoimmune hypothyroidism, myositis, myalgias, chronic fatigue, and failure to thrive. Genetic testing revealed heterozygosity for c.20_115de196 and c.967_979del13 mutations in the AIRE gene. The AIRE gene c.20_115de196 mutation has not been previously reported.


Corresponding author: Kelly Egan Huibregtse, MS, MD, 505 Parnassus Avenue, San Francisco, CA, USA, Phone: + 415-443-6332, E-mail: ; and Department of Pediatrics, University of California San Francisco, Benioff Children’s Hospital, San Francisco, CA, USA

References

1. Perheentupa J. APS-I/APECED: the clinical disease and therapy. Endocrinol Metab Clin N Am 2002;31:295–320, vi.10.1016/S0889-8529(01)00013-5Search in Google Scholar

2. Meloni A, Willcox N, Meager A, Atzeni M, Wolff AS, et al. Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab 2012;97:1114–24.10.1210/jc.2011-2461Search in Google Scholar PubMed

3. Scott HS, Heino M, Peterson P, Mittaz L, Lalioti MD, et al. Common mutations in autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy patients of different origins. Mol Endocrinol 1998;12:112–9.10.1210/mend.12.8.0143Search in Google Scholar PubMed

4. Ahonen P, Myllärniemi S. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990;322:1829–36.10.1056/NEJM199006283222601Search in Google Scholar PubMed

5. Rosatelli MC, Meloni A, Meloni A, Devoto M, Cao A, et al. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet 1998;103:428–34.10.1007/s004390050846Search in Google Scholar PubMed

6. Zlotogora J, Shapiro MS. 1992 Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet 1992;29: 824–6.10.1136/jmg.29.11.824Search in Google Scholar PubMed PubMed Central

7. Michels AW, Gottlieb PA. Autoimmune polyglandular syndromes. Nat Rev Endocrinol 2010;6:270–7.10.1038/nrendo.2010.40Search in Google Scholar PubMed

8. Eldershaw SA, Sansom DM, Narendran P. Expression and function of the autoimmune regulator (Aire) gene in non-thymic tissue. Clin Exp Immunol 2011;163:296–308.10.1111/j.1365-2249.2010.04316.xSearch in Google Scholar PubMed PubMed Central

9. Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 1997;17:399–403.10.1038/ng1297-399Search in Google Scholar PubMed

10. Cihakova D, Trebusak K, Heino M, Fadeyev V, Tiulpakov A, et al. Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED. Hum Mutat 2001;18:225–32.10.1002/humu.1178Search in Google Scholar PubMed

11. Akirav EM, Ruddle NH, Herold KC. The role of AIRE in human autoimmune disease. Nat Rev Endocrinol 2011;7:25–33.10.1038/nrendo.2010.200Search in Google Scholar PubMed

12. Anderson MS, Venazi ES, Chen Z, Berzins SP, Benoist C, et al. The cellular mechanism of Aire control of T cell tolerance. Immunity 2005;23:227–39.10.1016/j.immuni.2005.07.005Search in Google Scholar PubMed

13. Vogel A, Strassburg CP, Obermayer-Straub P, Brabant G, Manns MP. The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components. J Mol Med (Berl) 2002;80:201–11.10.1007/s00109-001-0306-2Search in Google Scholar PubMed

14. Scott HS, Heino M, Lalioti MD, Betterle C, Cohen A, et al. Common mutations in autoimmune ectodermal dystrophy patients of different origins. Mol Endocrinol 1998;12:1112–9.10.1210/mend.12.8.0143Search in Google Scholar PubMed

15. Ward L, Paquette J, Seidman E, Huot C, Alvarez F, et al. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J Clin Endocrinol Metab 1999;84:844–52.10.1210/jc.84.3.844Search in Google Scholar

16. Pearce SH, Cheetham T, Imrie H, Vaidya B, Barnes ND, et al. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinpathy type 1. Am J Hum Genet 1998;65:1675–84.10.1086/302145Search in Google Scholar PubMed PubMed Central

17. Padeh S, Theodor R, Jonas A, Passwell JH. Severe malabsorption in autoimmune dystrophy syndrome successfully treated with immunosuppression. Arch Dis Child 1997;76:532–4.10.1136/adc.76.6.532Search in Google Scholar PubMed PubMed Central

18. Vergani DM. Pharmacological management of autoimmune hepatitis. Expert opinion on pharmacotherapy. Arch Dis Child 2011;12:607–13.10.1517/14656566.2011.524206Search in Google Scholar PubMed

19. Cervato S, Mariniello B, Lazzarotto F, Morlin L, Zanchetta R, et al. Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives. Clin Endocrinol 2009;70:421–8.10.1111/j.1365-2265.2008.03318.xSearch in Google Scholar PubMed

20. Gentile NM, Murray JA, Pardi DS. Autoimmune enteropathy: a review and update of clinical management. Curr Gastroenterol Rep 2012;14:380–5.10.1007/s11894-012-0276-2Search in Google Scholar PubMed PubMed Central

21. Padeh S, Theodor R, Jonas A, Passwell JH. Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome successfully treated with immunosuppression. Arch Dis Child 1997;76:532–4.10.1136/adc.76.6.532Search in Google Scholar PubMed PubMed Central

Received: 2013-8-8
Accepted: 2014-5-8
Published Online: 2014-6-19
Published in Print: 2014-11-1

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Cushing syndrome
  3. Fundamental principles of clinical and biochemical evaluation underlie the diagnosis and therapy of Cushing’s syndrome
  4. Cushing syndrome secondary to CRH-producing Wilms tumor in a 6 year old
  5. Cushing’s disease presenting as cholestatic hepatitis
  6. How early can one diagnose Cushing’s disease? An early diagnosis in a case of prepubertal Cushing’s disease
  7. Review article
  8. Subclinical hypothyroidism in childhood and adolescense
  9. Original articles
  10. Energy substrate metabolism in pyruvate dehydrogenase complex deficiency
  11. Chromosome 6q24 transient neonatal diabetes mellitus and protein sensitive hyperinsulinaemic hypoglycaemia
  12. Measures of pituitary gland and stalk: from neonate to adolescence
  13. Are preterm newborns who have relative hyperthyrotropinemia at increased risk of brain damage?
  14. Pseudohypoparathyroidism vs. tricho-rhino-phalangeal syndrome: patient reclassification
  15. Association of serum 25-hydroxyvitamin D with race/ethnicity and constitutive skin color in urban schoolchildren
  16. A nonsense thyrotropin receptor gene mutation (R609X) is associated with congenital hypothyroidism and heart defects
  17. Acanthosis nigricans, vitamin D, and insulin resistance in obese children and adolescents
  18. Clinical characteristics and chromosome 11p15 imprinting analysis of Silver-Russell syndrome – a Chinese experience
  19. Change in reference body mass index percentiles and deviation in overweight and obesity over 3 years in Turkish children and adolescents
  20. Long-term outcomes of pediatric Graves’ disease
  21. Accessibility of the reference center as a protective factor against ketoacidosis at the onset of diabetes in children
  22. Vitamin D, parathormone, and insulin resistance in children born large for gestational age
  23. Prevalence of vitamin D deficiency in apparently healthy children in north India
  24. Prevalence of autoantibodies in type 1 diabetes patients and its association with the clinical presentation – UAE Eastern Region experience
  25. Clinical and molecular studies related to bone metabolism in patients with congenital adrenal hyperplasia
  26. Islet neogenesis-associated protein-related pentadecapeptide improves the function of allograft after islets transplantation
  27. Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents
  28. Early infant feeding practice and childhood obesity: the relation of breast-feeding and timing of solid food introduction with childhood obesity
  29. Late onset X-linked adrenal hypoplasia congenita with hypogonadotropic hypgonadism due to a novel 4-bp deletion in exon 2 of NR0B1
  30. The correlation between GnRH stimulation testing and obstetric ultrasonographic parameters in precocious puberty
  31. The DATAC study: a new growth database. Description of the epidemiology, diagnosis and therapeutic attitude in a group of Spanish children with short stature
  32. Concentrations of tumour necrosis factor-α and its soluble receptors in the serum of teenagers with atherosclerosis risk factors: obesity or obesity combined with hypertension
  33. Are HDL levels lower in children with type 1 diabetes and concurrent celiac disease compared with children with type 1 diabetes only?
  34. Patient reports
  35. Hereditary vitamin D rickets: a case series in a family
  36. Two heterozygous mutations of the AMH gene in a Japanese patient with persistent Müllerian duct syndrome
  37. Two case reports of severe pediatric hyperosmolar hyperglycemia and diabetic ketoacidosis accompanied with rhabdomyolysis and acute renal failure
  38. Acquired hypothyroidism due to iodine deficiency in an American child
  39. Continuous subcutaneous IGF-1 therapy via insulin pump in a patient with Donohue syndrome
  40. Amylase/creatinine clearance ratio in diabetic ketoacidosis: a case report
  41. Worsening hypertriglyceridemia with oral contraceptive pills in an adolescent with HIV-associated lipodystrophy: a case report and review of the literature
  42. Congenital hyperinsulinism in a newborn with a novel homozygous mutation (p.Q392H) in the ABCC8 gene
  43. Short communications
  44. Polyglandular autoimmune syndrome type I – a novel AIRE mutation in a North American patient
  45. Post-hemorrhagic hydrocephalus and diabetes insipidus in preterm infants
  46. Two novel mutations in acid α-glucosidase gene in two patients with Pompe disease
  47. Letter to the Editor
  48. And what about septin 9 (SEPT9) as a binding partner of survivin in heart regeneration?
Downloaded on 4.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0328/html
Scroll to top button